Marinus Pharmaceuticals Inc
NASDAQ:MRNS

Watchlist Manager
Marinus Pharmaceuticals Inc Logo
Marinus Pharmaceuticals Inc
NASDAQ:MRNS
Watchlist
Price: 0.55 USD Market Closed
Market Cap: 30.4m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

MRNS Price Targets Summary
Marinus Pharmaceuticals Inc

There are no price targets for MRNS.
MRNS Lowest Forecast
Wall Street Target
Not Available
MRNS Average Forecast
Wall Street Target
Not Available
MRNS Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Marinus Pharmaceuticals Inc Competitors:
Price Targets
4577
Daito Pharmaceutical Co Ltd
1% Upside
ZTS
Zoetis Inc
22% Upside
600195
China Animal Husbandry Industry Co Ltd
12% Upside
C
CONCORDBIO
Concord Biotech Ltd
25% Upside
4577
Daito Pharmaceutical Co Ltd
1% Upside
ZTS
Zoetis Inc
22% Upside
600195
China Animal Husbandry Industry Co Ltd
12% Upside
C
CONCORDBIO
Concord Biotech Ltd
25% Upside
4547
Kissei Pharmaceutical Co Ltd
6% Upside
A
AQST
Aquestive Therapeutics Inc
299% Upside
4568
Daiichi Sankyo Co Ltd
62% Upside

Revenue
Forecast

Revenue Estimate
Marinus Pharmaceuticals Inc

The compound annual growth rate of Marinus Pharmaceuticals Inc's revenue for the next 4 years is 36%.

N/A
Past Growth
36%
Estimated Growth
Estimates Accuracy
0%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Marinus Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Marinus Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-74%
Average Miss
What are analyst estimates?

See Also

Summary
MRNS intrinsic value, competitors valuation, and company profile.
DCF Valuation
MRNS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MRNS stock valuation using valuation multiples.
Wall Street Estimates
MRNS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MRNS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MRNS's stock price target?
Not Available

MRNS doesn't have any price targets made by Wall Street professionals.

What is Marinus Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
36%

The compound annual growth rate of Marinus Pharmaceuticals Inc's revenue for the next 4 years is 36%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 257,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.